Neuropharmacology publishes high quality, original research within the discipline of neuroscience. Papers within any area of
neuroscience that contain a significant neuropharmacological content are particularly encouraged, although submissions in any area of
neuroscience that is of interest to neuropharmacologists will be considered. The ... click here for full Aims & Scope
Neuropharmacology publishes high quality, original research within the discipline of neuroscience. Papers within any area of
neuroscience that contain a significant neuropharmacological content are particularly encouraged, although submissions in any area of
neuroscience that is of interest to neuropharmacologists will be considered. The journal does not, however, accept clinical research.
The journal publishes monthly articles of any length (original research and reviews).
The scope of the journal is broad and includes
for example, neurotransmitters and their receptors, ion channels, systems (e.g. cognitive function of hippocampus), behaviour, psychopharmacology
(animal models of psychiatric disorders), depression, epilepsy, ischaemia, neuroprotection, drugs of abuse and pain. The journal publishes
occasional Special Issues (and will consider publishing Supplements). Each year Elsevier/Neuropharmacology organise a satellite symposium
to the Meeting of the Society for Neuroscience. The journal publishes a Special Issue to accompany each meeting. Please see http://www.neuropharmacology-conference.elsevier.com/
for details of this year's meeting and accompanying Special Issue.
US National Institutes of Health (NIH) voluntary posting
("Public Access") policy
Neuropharmacology and Elsevier facilitate the author's response to the NIH Public Access Policy.
For more details please see the Guide
for authors
Hide Aims & Scope
Editor -in Chief Contact the Editor
Graham Collingridge
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company